LINC00511 and melanoma: Recently, emerging evidence has revealed that SLNCR1 is aberrantly expressed in various cancers, including malignant melanoma [6], nonsmall-cell lung cancer [7], breast cancer [8], pancreatic cancer [9], and cervical cancer [10], and promotes cancer cell migration, proliferation, and invasion.